Procarta Biosystems Limited

"Procarta Biosystems is an antibiotic drug discovery and development organisation with a unique platform that can identify new targets for antibiotics as well as discovering new drugs to kill even the most resistant bacteria. Procarta has discovered a new type of antimicrobial that kills bacteria by blocking their gene expression through a novel mechanism...

"Procarta is an antimicrobial drug discovery and development organisation with a unique platform that is developing a new type of antimicrobial: opening up bacterial transcription as a novel target. The proprietary antimicrobials are short fragments of DNA that invade the bacterial cell and kill by blocking gene expression through a novel mechanism of int...

Awaiting Public Project Summary

Procarta is developing a lasting solution to the treatment of bacterial infections using a proprietary technology platform based on nanoparticulate oligonucleotide therapeutics. This project will enable better understanding of how to formulate and manufacture novel nanoparticulate antibacterials, define and fix key QC parameters, leading to a production p...

Procarta is developing a lasting solution to the treatment of bacterial infections using a proprietary technology platform based on nanoparticulate oligonucleotide therapeutics. This project will enable better understanding of how to manufacture the delivery nanoparticles, define and fix key QC parameters, leading to a production process for scale up. Thi...

Procarta is investigating how safe and effective changes to the bacterial content in the human gut can reduce adverse side effects associated with the typical Western diet.